Medicare Enrolled
Dr. Peter Barcas, D.O.
Vascular Neurology Physician · Neptune, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barcas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barcas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barcas
Dr. Peter Barcas is a vascular neurology physician in Neptune, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Barcas performed 1,895 Medicare services across 1,189 unique beneficiaries.
Between the years covered by Open Payments, Dr. Barcas received a total of $9,373 from 74 pharmaceutical and/or device companies across 693 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in vascular neurology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barcas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in NJ
$9,373 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,895
Medicare services
Top 12% in NJ for vascular neurology physician
1,189
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~95 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Continuous intraoperative neurophysiology monitoring, remote Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments. |
477 | $27 | $225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
459 | $68 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
153 | $107 | $325 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
140 | $134 | $350 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
122 | $334 | $425 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
91 | $83 | $165 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
88 | $67 | $125 |
| Limited needle electromyography A test that measures the electrical activity in muscles of the arm, leg, trunk, or head using a needle electrode. This limited study evaluates muscle function and nerve health. |
87 | $16 | $243 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
83 | $98 | $170 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
50 | $97 | $275 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
25 | $40 | $110 |
| Central motor stimulation test of arms and legs This procedure involves placing skin electrodes on the body to measure how the central nervous system stimulates the muscles in the arms and legs. |
22 | $97 | $1,800 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
20 | $364 | $468 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs. |
19 | $35 | $1,800 |
| Needle EMG of muscles on both sides of body A test that measures the electrical activity in muscles using a needle electrode. The procedure is performed on muscles located on both sides of the body. |
16 | $52 | $500 |
| Placement of skin electrodes and measurement of stimulated sites in legs This procedure involves placing skin electrodes on the legs and measuring the sites where stimulation is applied. |
16 | $21 | $531 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $121 | $200 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
13 | $153 | $325 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,373
Total received (2018-2024)
Avg $1,339/year across 7 years
Top 11% in NJ for vascular neurology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
693
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,112 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$261 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,924
2023
$1,707
2022
$1,404
2021
$1,421
2020
$1,224
2019
$1,091
2018
$601
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$361
PFIZER INC.
$302
ABBVIE INC.
$264
ACADIA Pharmaceuticals Inc
$179
Lilly USA, LLC
$119
Teva Pharmaceuticals USA, Inc.
$108
Alexion Pharmaceuticals, Inc.
$72
UCB, Inc.
$67
Lundbeck LLC
$65
SCILEX PHARMACEUTICALS INC.
$65
ARGENX US, INC.
$45
Celgene Corporation
$33
Alnylam Pharmaceuticals Inc.
$31
CATALYST PHARMACEUTICALS, INC.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$29
Life Molecular Imaging Ltd
$27
CSL Behring
$27
Biogen, Inc.
$21
SK Life Science, Inc.
$19
Avadel CNS Pharmaceuticals, LLC
$17
Neurocrine Biosciences, Inc.
$15
Eisai Inc.
$15
Aucta Pharmaceuticals, Inc.
$13
Top 3 companies account for 48.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$967
Teva Pharmaceuticals USA, Inc.
$856
UCB, Inc.
$668
PFIZER INC.
$654
Alexion Pharmaceuticals, Inc.
$540
Lilly USA, LLC
$476
ABBVIE INC.
$437
AbbVie Inc.
$353
Biogen, Inc.
$315
ACADIA Pharmaceuticals Inc
$249
ARGENX US, INC.
$218
Sunovion Pharmaceuticals Inc.
$189
Janssen Pharmaceuticals, Inc
$180
SK Life Science, Inc.
$178
Biohaven Pharmaceutical Holding Company Ltd.
$169
Biohaven Pharmaceuticals, Inc.
$143
Lundbeck LLC
$135
Supernus Pharmaceuticals, Inc.
$130
CSL Behring
$116
E.R. Squibb & Sons, L.L.C.
$112
Kyowa Kirin, Inc.
$101
GENZYME CORPORATION
$99
Celgene Corporation
$89
NEUROPACE, INC.
$84
Acorda Therapeutics, Inc
$82
Avanir Pharmaceuticals, Inc.
$82
Eisai Inc.
$81
Amneal Pharmaceuticals LLC
$78
Mallinckrodt Hospital Products Inc.
$77
SCILEX PHARMACEUTICALS INC.
$77
Philips Electronics North America Corporation
$76
Currax Pharmaceuticals LLC
$73
Neurelis, Inc.
$70
Grifols USA, LLC
$68
EMD Serono, Inc.
$56
Medtronic USA, Inc.
$55
Allergan Inc.
$55
Amgen Inc.
$54
US WorldMeds, LLC
$51
Scilex Pharmaceuticals Inc.
$48
IMPEL PHARMACEUTICALS INC.
$47
Genentech USA, Inc.
$45
Sumitomo Pharma America, Inc.
$45
Neurocrine Biosciences, Inc.
$44
ARBOR PHARMACEUTICALS, INC.
$43
Bausch Health US, LLC
$41
AstraZeneca Pharmaceuticals LP
$39
Merz North America, Inc.
$33
Alnylam Pharmaceuticals Inc.
$31
Catalyst Pharmaceuticals, Inc.
$31
CATALYST PHARMACEUTICALS, INC.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$29
Allergan, Inc.
$29
Life Molecular Imaging Ltd
$27
Horizon Therapeutics plc
$27
Corium, LLC
$27
Impax Laboratories, Inc.
$26
Ventec Life Systems, Inc.
$18
Avadel CNS Pharmaceuticals, LLC
$17
JAZZ PHARMACEUTICALS INC.
$15
EISAI INC.
$15
AQUESTIVE THERAPEUTICS, INC.
$15
GE HealthCare
$15
Adamas Pharmaceuticals, Inc.
$14
AbbVie, Inc.
$14
Amylyx Pharmaceuticals, Inc.
$14
Assertio Therapeutics, Inc.
$14
Aucta Pharmaceuticals, Inc.
$13
Strongbridge US INC.
$13
Akcea Therapeutics, Inc.
$13
ASSERTIO THERAPEUTICS, INC.
$13
Validus Pharmaceuticals LLC
$12
Boston Scientific Corporation
$12
W. L. Gore & Associates, Inc.
$12
Top 3 companies account for 26.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · CAMBIA · COMIRNATY · COPAXONE · Cambia · ELYXYB · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Equetro · FYCOMPA · Fycompa · GOCOVRI · GORE CARDIOFORM Septal Occluder · Gamunex-C · General - DBS · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · LEMTRADA · LUMRYZ · LYRICA · Leqembi · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NEURACEQ · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONZETRA XSAIL · Ongentys · PANZYGA · PAXLOVID · Ponvory · QULIPTA · RELYVRIO · REXULTI · REYVOW · RNS Neurostimulator Kit · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SYMPAZAN · Soliris · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XEOMIN · Xadago · ZEPOSIA · ZTLido · Zinbryta · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Vascular neurology physicians within 10 mi
3
Per 100K population
0.5
County median income
$122,727
Nearest hospital
MONMOUTH MEDICAL CENTER
7.4 mi
7.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Barcas is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NJ), with low-engagement industry engagement in the top 11% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Barcas experienced with continuous intraoperative neurophysiology monitoring, remote?
Based on Medicare claims data, Dr. Barcas performed 477 continuous intraoperative neurophysiology monitoring, remote services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barcas receive payments from pharmaceutical companies?
Yes. Dr. Barcas received a total of $9,373 from 74 companies across 693 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barcas's costs compare to other vascular neurology physicians in Neptune?
Dr. Barcas's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barcas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Vascular Neurology Physicians in Neptune
Browse vascular neurology physicians in Neptune ranked by procedure volume and transparency data.
Highest volume
Top Vascular Neurology Physicians in NJ
Vascular neurology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Vascular Neurology Physicians in NJ
Which NJ vascular neurology physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology